Blogs and Publications

Sending the Ladder Down While Still Climbing

August 11, 2020

Chris Gibson, PhD

The Bio-ML Revolution: Who Will Be Drug Discovery’s Next Big Player?

February 7, 2020

Inclusion: Let's Keep Learning Together

January 28, 2020

Presidential Reflections… Before Another Big Year

January 9, 2020

How Recursion Built a High Throughput Screening Lab Capable of Producing Four Petabytes of Biological Data

December 12, 2019

Why Tech and Biotech VCs Talk Past Each Other

November 7, 2019

Last Week was Big for AI and Pharma

October 7, 2019

Building a Start-up Ecosystem for Utah Biotech Entrepreneurs

February 28, 2019

Tina Larson & Christopher Gibson

Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2

January 4, 2019

Empowering host factors to eradicate malaria

Cell Painting, A high-content image-based assay for morphological profiling using multiplexed fluorescent dyes

September 28, 2017

Christopher C Gibson

Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation

September 28, 2017

Deep Learning and Biology: We've only just begun

August 22, 2017

Batch- vs Stream-Processing: Distributed Computing for Biology

August 10, 2017

Calculating the incalculable

AI-Enabled Phenotrpic Screens Reveal Clinically Relevant Drugs

Recursion Pharmaceuticals

Welcoming our new Chief Scientific Officer, Dr. Sharath Hegde